InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by RUDNICK SETH, Director. Officer active across 1 companies, notably G1 Therapeutics, Inc.. Cumulatively, 4 filings have been recorded. The latest transaction was disclosed on 29 June 2021 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations4 total
€2,6117,969 shares@ €0.3277100.0% of flow
Common Stock
SEC:0001562180-21-004586·
€2,6117,969 shares@ €0.327750.0% of flow
Common Stock
SEC:0001562180-21-004586:0·
04,389 shares0
Common Stock
SEC:0001562180-21-004395·
04,389 shares0
Common Stock
SEC:0001562180-21-004395:0·
4 of 4 declarations
About RUDNICK SETH
Seth Rudnick is a Director at G1 Therapeutics, Inc. In this role, he contributes to the governance of the company and the strategic direction of its operations. G1 Therapeutics is a biopharmaceutical company focused on developing innovative treatments for cancer. Seth brings significant expertise in the field, supporting the company's efforts to improve patient outcomes.
